(NasdaqGM:NTLA), CAMBRIDGE, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that the company will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 14, 2026 at 9:00 a.m. PT. A live […]
(XETRA:SHLG), Tarrytown, New York, Jan. 07, 2026 (GLOBE NEWSWIRE) — 93% of patients expect their doctor to order a test upon request 17% have requested a lab test they learned about from social media 27% have pursued a blood test, independent of a doctor's recommendation A national survey of 1,000 U.S.-based patients conducted by YouGov
(NASDAQ:SDST),(NASDAQ:SDSTW), GREENWICH, Conn., Jan. 07, 2026 (GLOBE NEWSWIRE) — Stardust Power Inc. (NASDAQ: SDST) (“Stardust Power” or “the Company”), an American developer of battery-grade lithium carbonate, announced today that it has engaged 38 North Solutions, LLC (“38 North”), a leading Washington, D.C. based government relations and strategic advisory firm, to support the Company's federal policy,
TORONTO & PALO ALTO, Jan. 07, 2026 (GLOBE NEWSWIRE) — FreshBooks, a platform designed to simplify the financial complexity of running a service based small business, today announced a strategic partnership with Kick. Kick is a bookkeeping platform backed by OpenAI, Google Ventures, and General Catalyst, designed for business owners and their accountants. Through this
(NasdaqGM:TSPY),(CBOE:TDAQ), SEATTLE, Jan. 07, 2026 (GLOBE NEWSWIRE) — TappAlpha and Tuttle Capital Management, two innovators in ETF design, today jointly announced the launch of the T(2) Lift(TM) Series — a new line of ETFs seeking to offer light-leverage exposure to the daily income and growth strategies behind TSPY and TDAQ. The T(2) Lift(TM) Series aims
BrainsWay Announces First Coverage Policy for Accelerated Deep TMS(TM) New Premera Blue Cross Blue Shield(R) policy extends to both adolescent and adult depression patients GlobeNewswire January 07, 2026 BURLINGTON, Mass. and JERUSALEM, Jan. 07, 2026 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain
Capital Power extends its Arlington Valley tolling agreement to 2038 and increases its summer capacity by 35 MWs, enhancing reliability and long-term value GlobeNewswire January 07, 2026 Extends Arlington Valley (Arlington) tolling agreement with the current counterparty by 7 years through 2038, increasing the remaining contract life to 13 years Adds 35 MW of incremental
TG Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference Presentation scheduled for Tuesday, January 13, 2026, at 1:30 PM PST GlobeNewswire January 07, 2026 NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss, the Company's Chairman and Chief Executive Officer, will present
Sotera Health to Present at the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire January 07, 2026 CLEVELAND, Jan. 07, 2026 (GLOBE NEWSWIRE) — Sotera Health Company (“Sotera Health” or the “Company”) (NASDAQ: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced that management
Palvella Therapeutics Strengthens Leadership Team with Appointment of Veteran Medical Affairs Leader Vimal Patel, PharmD, as Senior Vice President of Medical Affairs GlobeNewswire January 07, 2026 Seasoned dermatology and immunology executive brings more than 25 years of experience advancing and launching innovative therapies, including OPZELURA(R), povorcitinib, ILUMYA(R), ODOMZO(R), REMICADE(R), and STELARA(R) Dr. Patel to lead